These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38995732)
1. Isobavachalcone Exhibits Potent Antifungal Efficacy by Inhibiting Enolase Activity and Glycolysis in Wu H; Ji Z; Huang X; Li L; Hang S; Yu J; Lu H; Jiang Y ACS Infect Dis; 2024 Aug; 10(8):3059-3070. PubMed ID: 38995732 [TBL] [Abstract][Full Text] [Related]
2. Baicalein Acts against Candida albicans by Targeting Eno1 and Inhibiting Glycolysis. Li L; Lu H; Zhang X; Whiteway M; Wu H; Tan S; Zang J; Tian S; Zhen C; Meng X; Li W; Zhang D; Zhang M; Jiang Y Microbiol Spectr; 2022 Aug; 10(4):e0208522. PubMed ID: 35900099 [TBL] [Abstract][Full Text] [Related]
3. Generation and Characterization of Single Chain Variable Fragment against Alpha-Enolase of Leu SJ; Lee YC; Lee CH; Liao PY; Chiang CW; Yang CM; Su CH; Ou TY; Liu KJ; Lo HJ; Tsai BY; Yang YY Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326294 [No Abstract] [Full Text] [Related]
4. Isobavachalcone exhibits antifungal and antibiofilm effects against Qian W; Lu J; Gao C; Liu Q; Yao W; Wang T; Wang X; Wang Z Front Cell Infect Microbiol; 2024; 14():1336773. PubMed ID: 38322671 [TBL] [Abstract][Full Text] [Related]
5. Preventing Chen SM; Zou Z; Guo SY; Hou WT; Qiu XR; Zhang Y; Song LJ; Hu XY; Jiang YY; Shen H; An MM Emerg Microbes Infect; 2020 Dec; 9(1):2417-2432. PubMed ID: 33115324 [No Abstract] [Full Text] [Related]
6. Mutations on CaENO1 in Candida albicans inhibit cell growth in the presence of glucose. Yang YL; Chen HF; Kuo TJ; Lin CY J Biomed Sci; 2006 May; 13(3):313-21. PubMed ID: 16453178 [TBL] [Abstract][Full Text] [Related]
7. Soluble Enolase 1 of Candida albicans and Aspergillus fumigatus Stimulates Human and Mouse B Cells and Monocytes. Langenhorst D; Fürst AL; Alberter K; Vilhena C; Dasari P; Daud M; Heilig L; Luther CH; Dittrich M; Reiher N; Wich M; Elmowafy M; Jacobsen ID; Jungnickel B; Zipfel PF; Beyersdorf N J Immunol; 2023 Sep; 211(5):804-815. PubMed ID: 37436030 [TBL] [Abstract][Full Text] [Related]
8. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079 [TBL] [Abstract][Full Text] [Related]
9. Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence. Ko HC; Hsiao TY; Chen CT; Yang YL J Microbiol; 2013 Jun; 51(3):345-51. PubMed ID: 23812815 [TBL] [Abstract][Full Text] [Related]
10. D319 induced antifungal effects through ROS-mediated apoptosis and inhibited isocitrate lyase in Candida albicans. Ding Y; Zhang K; Yin Y; Wu J Biochim Biophys Acta Gen Subj; 2022 Feb; 1866(2):130050. PubMed ID: 34800580 [TBL] [Abstract][Full Text] [Related]
11. Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target. Demuyser L; Palmans I; Vandecruys P; Van Dijck P mSphere; 2020 Aug; 5(4):. PubMed ID: 32759338 [No Abstract] [Full Text] [Related]
13. The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans. Wang YH; Dong HH; Zhao F; Wang J; Yan F; Jiang YY; Jin YS Bioorg Med Chem Lett; 2016 Jul; 26(13):3098-3102. PubMed ID: 27210436 [TBL] [Abstract][Full Text] [Related]
14. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL mBio; 2017 Dec; 8(6):. PubMed ID: 29208749 [No Abstract] [Full Text] [Related]
15. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. Angiolella L; Facchin M; Stringaro A; Maras B; Simonetti N; Cassone A J Infect Dis; 1996 Mar; 173(3):684-90. PubMed ID: 8627033 [TBL] [Abstract][Full Text] [Related]
16. An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Lin YH; Satani N; Hammoudi N; Yan VC; Barekatain Y; Khadka S; Ackroyd JJ; Georgiou DK; Pham CD; Arthur K; Maxwell D; Peng Z; Leonard PG; Czako B; Pisaneschi F; Mandal P; Sun Y; Zielinski R; Pando SC; Wang X; Tran T; Xu Q; Wu Q; Jiang Y; Kang Z; Asara JM; Priebe W; Bornmann W; Marszalek JR; DePinho RA; Muller FL Nat Metab; 2020 Dec; 2(12):1413-1426. PubMed ID: 33230295 [TBL] [Abstract][Full Text] [Related]
17. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer. Qian X; Xu W; Xu J; Shi Q; Li J; Weng Y; Jiang Z; Feng L; Wang X; Zhou J; Jin H Oncotarget; 2017 Jul; 8(29):47691-47708. PubMed ID: 28548950 [TBL] [Abstract][Full Text] [Related]
18. Enolase 1 of Candida albicans binds human CD4 Daud M; Dasari P; Adelfinger M; Langenhorst D; Lother J; Slavkovic-Lukic D; Berges C; Kruhm M; Galler A; Schleussner C; Luther CH; Alberter K; Althammer A; Shaikh H; Pallmann N; Bodem J; El-Mowafy M; Beilhack A; Dittrich M; Topp MS; Zipfel PF; Beyersdorf N Eur J Immunol; 2023 Nov; 53(11):e2250284. PubMed ID: 37503840 [TBL] [Abstract][Full Text] [Related]
19. Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis. Ishida K; Fernandes Rodrigues JC; Cammerer S; Urbina JA; Gilbert I; de Souza W; Rozental S Ann Clin Microbiol Antimicrob; 2011 Jan; 10():3. PubMed ID: 21255433 [TBL] [Abstract][Full Text] [Related]
20. Als3-mediated attachment of enolase on the surface of Candida albicans cells regulates their interactions with host proteins. Karkowska-Kuleta J; Wronowska E; Satala D; Zawrotniak M; Bras G; Kozik A; Nobbs AH; Rapala-Kozik M Cell Microbiol; 2021 Apr; 23(4):e13297. PubMed ID: 33237623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]